Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Coast Radiology takes RealTimeImage iPACS

Coast Radiology and Medical Imaging has selected RealTimeImage to implement an advanced web-based PACS to provide immediate access to medical images from multiple locations.

Misys Healthcare Systems lands 15 new accounts

Misys Healthcare Systems has announced that 15 medical practices recently selected the company's clinical technology products.

WedMD to acquire Dakota Imaging

WebMD Corp. plans to acquire Dakota Imaging Inc., a privately held provider of automated healthcare claims processing technology and business process outsourcing (BPO) services.

Actuality System introduces spatial 3D interventional planning tool for research

Actuality Systems Inc. has released Perspecta Medical, a spatial 3D system for surgical and interventional planning for use in research.

College of American Pathologists licenses SNOMED to Cerner

The College of American Pathologists (CAP) has signed a five-year agreement with Cerner Corp. licensing SNOMED Clinical Terms (SNOMED CT) Core Content for unlimited global distribution.

Toshiba introduces new digital platform for Infinix i-series vascular x-ray system

Toshiba America Medical Systems Inc. this week introduced its new Digital Fluorography Processor 8000 (DFP-8000D) for its entire Infinix i-series systems with the new software upgrade (version V3.10) for enhanced productivity and patient care.

Lawsuits blossom as US Oncology mulls buyout offer

US Oncology Inc. is facing two class action lawsuits in the wake of its proposed merger agreement with investment partnership Welsh, Carson, Anderson & Stowe IX LP.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.